Global Continuous Positive Airway Pressure – Market Overview
High prevalence of sleep disorders, growing awareness of sleep apnea related comorbid conditions such as high blood pressure, obesity have led to increased demand for Continuous Positive Airway Pressure Devices market research. Similarly, advances in technology such as use of oxygen devices, improved mask design and oral appliances are expected to provide support and propel the growth of the global continuous positive airway pressure market.
Continuous positive airway pressure therapy is the most widely recognized treatment for obstructive Sleep Apnea that utilizes continuous mild air pressure. These devices are utilized to keep the airways open during sleep and furthermore to control the yield pressure keeping the airflow pressure constant.
Recently, FDA cleared World’s Smallest CPAP, ResMed AirMini™, expected to boost CPAP market growth. Portable AirMini offers ease-of-use and comfort for travelers and additional revenue opportunities for home medical equipment providers.
ResMed announced that the U.S. Food and Drug Administration has cleared ResMed’s AirMini, the world’s smallest continuous positive airway pressure (CPAP) device. ResMed’s tiny yet fully-featured AirMini, is designed as a secondary CPAP, making it easier for people to continue their sleep apnea therapy while traveling. As an addition to ResMed’s industry-leading Air Solutions portfolio, the AirMini offers multiple benefits to home medical equipment providers supporting increased therapy compliance convenience for their patients, incremental revenue opportunities. ResMed AirMini is the portable travel CPAP patients and home medical equipment providers have been waiting for, and the company looks forward to bringing it to market. It fits easily in carry-on luggage even in the seatback pocket on the plane delivers all the best-in-class comfort features patients need to get the best sleep.
Global Continuous Positive Airway Pressure Market – Competitive Analysis
As the market seems to be attractive, growing and profitable, at the same time the market has witnessed intense rivalry among existing competitors. There are many big Continuous Positive Airway Pressure Devices market players such as: Resumed (Asia), Philips Healthcare (US), Fisher Paychex (NZ), 3B Medical (US), Apex Medical (Taiwan), Apria Healthcare (US), Armstrong Medical (UK), BMC Medical (China), Cardinal Health (US), Curative Medical (US)
Global Continuous Positive Airway Pressure Market – Regional Analysis
Geographically, the CPAP devices market has been devided into North America, Europe, Asia Pacific, and Middle East Africa. The CPAP devices market is currently dominated by the Americas, accounting for more than half market share, followed by the Middle East Africa region the Asia Pacific region. In the Americas, the U.S. was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients. Similarly, Asia Pacific is expected to witness higher growth in the CPAP devices market due to increasing disease prevalence in countries like India China. The market will typically witness a strong growth rate in countries such as Germany, Spain, U.K., Italy France. The CPAP devices market in the U.K. is developed and well-established, is comparatively easier to enter the market for new players, making the positive airway pressure devices market in the country more prominent than in any other European countries. The growth of this market in Europe is due to well-defined regulatory guidelines and increasing prevalence of sleep apnea.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team has the supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
